Hepatology(Liver, Pancreatic, Gall Bladder)

  • Home
  • Hepatology(Liver, Pancreatic, Gall Bladder)
EL CENTRO: Engaging Latinos in the Center of Cancer Treatment Options

Conditions:   Metastatic Pancreatic Cancer;   Unresectable Pancreatic Cancer;   Metastatic Colorectal Cancer
Interventions:   Behavioral: Usual chemotherapy education (CE);   Behavioral: Chemotherapy education intervention (CEI)
Sponsors:   Dana-Farber Cancer Institute;   National Cancer Institute (NCI)
Not yet recruiting
ClinicalTrials.gov: Pancreatic | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

September 19, 2018 / by / in
Neoadjuvant Chemotherapy With Gemcitabine Plus Cisplatin Followed by Radical Liver Resection Versus Immediate Radical Liver Resection Alone With or Without Adjuvant Chemotherapy in Incidentally Detected Gallbladder Carcinoma After Simple Cholecystectomy or in Front of Radical Resection of BTC

Conditions:   Incidental Gallbladder Carcinoma;   Biliary Tract Cancer
Interventions:   Drug: Gemcitabine;   Drug: Cisplatin;   Procedure: Oncologically radical margin-free (R0) resection;   Drug: Adjuvant chemotherapy
Sponsors:   Krankenhaus Nordwest;   German Research Foundation
Not yet recruiting
ClinicalTrials.gov: Gall Bladder | Recruiting, Not yet recruiting, Available Studies | First posted in the last 100 days

September 18, 2018 / by / in
Xenotransplantation of Primary Cancer Samples in Zebrafish Embryos

Conditions:   Liver Cancer;   Pancreatic Cancer;   Gastric Cancer;   Esophageal Cancer;   Colo-rectal Cancer;   Gall Bladder Cancer;   Biliary Tract Cancer
Interventions:   Drug: Fluorouracil;   Drug: Lederfolin;   Drug: Oxaliplatin;   Drug: Irinotecan;   Drug: Docetaxel;   Drug: Cisplatin;   Drug: Epirubicin;   Drug: Gemcitabine;   Drug: Nab paclitaxel
Sponsors:   University of Pisa;   Azienda Ospedaliero, Universitaria Pisana
Recruiting
ClinicalTrials.gov: Gall Bladder | Recruiting, Not yet recruiting, Available Studies | First posted in the last 100 days

September 17, 2018 / by / in
Pediatric Longitudinal Cohort Study of Chronic Pancreatitis

Conditions:   Pancreatitis, Chronic;   Pancreatitis, Acute
Interventions:   Diagnostic Test: Blood sample;   Behavioral: Patient questionnaires
Sponsors:   Aliye Uc;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   National Cancer Institute (NCI)
Recruiting
ClinicalTrials.gov: Pancreatic | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

September 16, 2018 / by / in
EnVision CF Multicenter Study of Glucose Tolerance in Cystic Fibrosis

Condition:   Cystic Fibrosis-related Diabetes
Interventions:   Diagnostic Test: Oral glucose tolerance test;   Diagnostic Test: Continuous glucose monitoring;   Diagnostic Test: Dexa scan
Sponsor:   Katie Larson Ode
Not yet recruiting
ClinicalTrials.gov: Pancreatic | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

September 14, 2018 / by / in
Quality of Life Assessment of Chronic Pancreatitis Endoscopic Interventions

Condition:   Chronic Pancreatitis
Intervention:   Other: PANQOLI (quality of life instrument)
Sponsors:   University of Colorado, Denver;   Johns Hopkins University
Recruiting
ClinicalTrials.gov: Pancreatic | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

September 13, 2018 / by / in
Diabetes and Osteopathic Manipulative Medicine (OMM)

Conditions:   Type2 Diabetes Mellitus;   Osteopathy in Diseases Classified Elsewhere
Interventions:   Procedure: OMT Protocol;   Procedure: OMT-Sham Protocol
Sponsors:   New York Institute of Technology;   American Osteopathic Association
Recruiting
ClinicalTrials.gov: Pancreatic | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

September 11, 2018 / by / in
Study of Nivolumab, Cabiralizumab, and Stereotactic Body Radiotherapy (SBRT) for Locally Advanced Unresectable Pancreatic Cancer

Condition:   Pancreatic Cancer
Interventions:   Drug: Nivolumab + Cabiralizumab;   Radiation: Stereotactic Body Radiotherapy (SBRT)
Sponsor:   New York University School of Medicine
Recruiting
ClinicalTrials.gov: Pancreatic | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

September 10, 2018 / by / in